Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reintroduction of Anti-TB Drugs After Hepatotoxicity
NCT00405301Phase 4Completed
- Sponsor
- AIIMS New Delhi
- Start
- Dec 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of isoniazid, rifampicin, pyrazinamide in Tuberculosis (TB), sponsored by AIIMS New Delhi. Started Dec 2006; status: completed.
02
Drugs
isoniazidrifampicinpyrazinamide
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00405301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405301.